YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FGGQ3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,889
Award facts
- Contract value 100% obligated
- $1,888.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $1,888.62 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (Yellow Fever vaccine) in one-dose vials. This delivery order, awarded on January 28, 2026, with an ultimate completion date of February 19, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group is established as a regional prime vendor contractor under the PPV-G GEN V program, which authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables. The company's product portfolio encompasses a wide range of pharmaceuticals including vaccines, specialty medications, and routine drugs required to support military healthcare operations globally. With its SAM registration dating to July 2001 and demonstrated substantial federal contracting activity, DMS Pharmaceutical Group has established itself as a critical supplier within the Department of Defense's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FGGQ3?
SPE2DR26FGGQ3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FGGQ3 worth?
The government has obligated $1,889 on SPE2DR26FGGQ3.
Is contract SPE2DR26FGGQ3 an order under another contract?
Yes. SPE2DR26FGGQ3 is a delivery order under SPE2DR25D9349, an indefinite delivery contract.
Was contract SPE2DR26FGGQ3 competed?
The extent of competition for SPE2DR26FGGQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award